SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-030930
Filing Date
2019-05-22
Accepted
2019-05-22 06:10:11
Documents
1
Period of Report
2019-05-22
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K a19-9697_48k.htm 8-K 22366
  Complete submission text file 0001104659-19-030930.txt   23387
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 19844109
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1